May 1, 2018

Examining Value Assessment Frameworks, Healthcare Economic Information, and more at ISPOR 2018 Baltimore

Xcenda's global HEOR experts join more than 4,200 attendees from around the world at ISPOR 2018 in Baltimore, Maryland. Timely topics such as healthcare economic information (HCEI) and value assessment frameworks will be our focus. Meet us at booth #801 to meet our team and learn more. 

Optimizing Outcomes for Our Partners

Join us in Baltimore and learn how we can optimize your brand's access.

Baltimore skyline

2018 Presentation Highlights

Headshot of Kristen Migliaccio-Walle

Wednesday, May 23 | 8:30 AM - 9:30 AM ET

ISSUE PANEL: Value Assessment Frameworks in an Era of Personalized Medicine: Shared Objectives or Irreconcilable Differences?

Headshot of Kristen Migliaccio-Walle
Moderator: Kristen Migliaccio-Walle, BS, Director, Global HEOR, Xcenda

Panelists: Dan Ollendorf, PhD, Chief Scientific Officer for the Institute of Clinical and Economic Review (ICER); Robert W. Dubois, MD, PhD
Chief Science Officer & Executive Vice President, National Pharmaceutical Council (NPC); Sara Traigle van Geertruyden, JD, Executive Director, Partnership to Improve Patient Care (PIPC)

By identifying which medical treatments and procedures will work best for each patient, personalized medicine improves efficiency at both the individual and health system levels. In an environment where the US has paid increasing attention to health care costs, VAFs aim to systematically quantify which treatments provide the most benefit for patients and the health system at a reasonable cost. Indeed, the two share many objectives related to improving health outcomes. Nevertheless, the current methodologies of VAFs may not sufficiently capture the value of personalized medicine, focusing instead on population health, thereby overlooking efficiencies in patient-level health care and potentially under-valuing innovative therapies. This panel aims to expose and debate the challenges of valuing personalized medicines in the current VAF environment and identify areas of consensus on which newer methodologies can be built.

Headshot of Kristen Migliaccio-Walle

Podium and Poster Presentations

Podium Presentation | Wednesday, May 23 | 8:30 AM - 9:30 AM

  • Budget Impact Analysis with Simultaneous Multiple Market Entrants: Static Versus Dynamic Baseline Market
    Authors: Ken O’Day, PhD, MPA; Kellie Meyer, PharmD, MPH
Poster Session I | Monday, May 21 | 8:30 AM - 2:00 PM
Poster Session II | Monday, May 21 | 3:30 PM - 7:30 PM
Poster Session III | Tuesday, May 22 | 8:30 AM - 2:00 PM
Poster Session IV | Tuesday, May 22 | 3:30 PM - 7:30 PM
Poster Session V | Wednesday, May 23 | 8:30 AM - 2:00 PM

Manufacturers: We want to hear from you...

Take our manufacturer survey regarding policy impacts on proactive communication of healthcare economic information (HCEI).

Young man taking survey on iPad